spacer
home > pmps > autumn 2008 > the future’s bright
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Future’s Bright

How do you think your sector has developed over the past 10 years?

Temperature controlled packaging has become a defined sector in the last 10 years, driven by the increasing use of biological products in the healthcare sector, such as erythropoietins for the treatment of anaemia and beta interferons for multiple sclerosis, anti-inflammatories and cancer treatments. These largely protein-based products are highly sensitive to temperature, requiring careful storage and distribution in order to be effective. The range from +2 to +8°C is such a prevalent specification that it has become a de facto standard. Other temperature requirements have since emerged, most notably temperate (+15 to +25 or +30°C). Regulatory awareness, notably that of the US FDA and the UK’s MHRA, and industry practice in the form of GxPs have kept pace with these demands, as has an array of shipping technologies, both passive and active.

What would you perceive as the biggest challenges facing the industry over the next 10 years?

The challenge now is to harmonise standards across an increasingly global platform. Industrial and international cooperation...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Tim Jennings is a Director of the French company Emball’iso SA and of two of its international affiliates. He has 10 years’ experience in the shipping of temperature sensitive products at two of the leading European companies in the field. Prior to these commercial roles Tim worked in the supply of engineering design and consultancy services to the pharmaceutical and petrochemical industries, specialising in ion exchange and adsorbent processes. Tim has a BSc (Hons) in Materials Technology.
spacer
Tim Jennings
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sustainability, plastics and Brexit: Keynote speakers set to inspire at PPMA Total Show 2019

Experts from IKEA, the British Plastics Federation and The Sunday Times to create a forum for education, knowledge-sharing and debate
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement